Cinzia Dello Russo Selected Research

Cinzia Dello Russo Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 07/2014
5	Pain (Aches) 10/2023 - 03/2009
4	Multiple Sclerosis 01/2021 - 11/2005
4	Glioma (Gliomas) 01/2017 - 08/2002
4	Hypersensitivity (Allergy) 05/2016 - 04/2011
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2013 - 02/2002
3	Disease Progression 03/2013 - 11/2005
2	Hyperalgesia 11/2023 - 03/2013
2	Chronic Pain 10/2023 - 01/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 11/2009
2	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 10/2003
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2012
2	Inflammation (Inflammations) 01/2012 - 11/2002
2	Migraine Disorders (Migraine) 05/2011 - 08/2009
2	Neuroinflammatory Diseases 11/2009 - 02/2002
1	Postoperative Pain 10/2023
1	Cognitive Dysfunction 05/2022
1	Hearing Loss (Hearing Impairment) 01/2022
1	Ototoxicity 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Neuroblastoma 09/2015
1	Neuralgia (Stump Neuralgia) 01/2015
1	Cancer Pain 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2012
1	Infections 01/2012
1	Hypoxia (Hypoxemia) 11/2009
1	Demyelinating Diseases (Demyelinating Disease) 11/2005
1	Brain Neoplasms (Brain Tumor) 03/2004
1	Brain Diseases (Brain Disorder) 11/2002

Drug/Important Bio-Agent (IBA)

4	abacavir (Ziagen)FDA Link 05/2016 - 04/2011
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2022 - 11/2002
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 03/2013
3	HLA-B57 antigenIBA 05/2016 - 04/2011
3	Phosphotransferases (Kinase)IBA 01/2015 - 03/2013
3	CytokinesIBA 04/2011 - 11/2002
2	Remifentanil (Ultiva)FDA Link 11/2023 - 01/2023
2	Analgesics (Analgesic Drugs)IBA 10/2023 - 03/2009
2	Dimethyl FumarateIBA 01/2021 - 04/2011
2	LigandsIBA 01/2019 - 11/2005
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2012
2	TOR Serine-Threonine KinasesIBA 01/2015 - 07/2014
2	Macrocyclic LactamsIBA 02/2013 - 02/2002
2	Calcitonin Gene-Related PeptideIBA 08/2011 - 08/2009
2	LipopolysaccharidesIBA 04/2011 - 03/2004
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2009 - 02/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2009 - 02/2002
1	Neuroprotective AgentsIBA 05/2022
1	ChemokinesIBA 05/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	PlatinumIBA 01/2022
1	Nerve Growth Factors (Neurotrophins)IBA 12/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2020
1	pembrolizumabIBA 01/2019
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 01/2017
1	Messenger RNA (mRNA)IBA 09/2015
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 09/2015
1	Cyclin-Dependent Kinase Inhibitor p27IBA 09/2015
1	Corticotropin-Releasing HormoneIBA 09/2015
1	Interleukin-10 (Interleukin 10)IBA 07/2014
1	Everolimus FDA Link 07/2014
1	Conditioned Culture MediaIBA 07/2014
1	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 02/2013
1	Maraviroc FDA Link 01/2012
1	Chemokine ReceptorsIBA 01/2012
1	Tryptamines (Triptans)IBA 05/2011
1	Sumatriptan (Imigran)FDA LinkGeneric 05/2011
1	BradykininIBA 05/2011
1	Transcription Factors (Transcription Factor)IBA 04/2011
1	NitritesIBA 04/2011
1	InterferonsIBA 04/2011
1	Oxygen (Dioxygen)IBA 11/2009
1	Glucose (Dextrose)FDA LinkGeneric 11/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2009
1	Opioid Analgesics (Opioids)IBA 03/2009
1	Formaldehyde (Formol)FDA Link 03/2009
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2006
1	tanespimycin (17AAG)IBA 12/2006
1	geldanamycinIBA 12/2006
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2005
1	PPAR gammaIBA 11/2005
1	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 11/2005
1	PPAR deltaIBA 11/2005
1	Temozolomide (Temodar)FDA LinkGeneric 03/2004
1	Antineoplastic Agents (Antineoplastics)IBA 03/2004
1	Methotrexate (Mexate)FDA LinkGeneric 03/2004
1	Cytokine Receptors (Cytokine Receptor)IBA 11/2002
1	Immunologic Factors (Immunomodulators)IBA 11/2002
1	I-kappa B Proteins (I kappa B)IBA 08/2002
1	NF-kappa B (NF-kB)IBA 08/2002
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2002
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2011
2	Drug Therapy (Chemotherapy) 01/2022 - 03/2004
1	Analgesia 10/2023
1	Highly Active Antiretroviral Therapy (HAART) 01/2012
1	Secondary Prevention 04/2011